MYL2 as a potential predictive biomarker for rhabdomyosarcoma.

Wang, Junning; Gao, Shang; Dong, Keqin; Guo, Peiyuan; Shan, Meng-Jie

Wang, Junning; Gao, Shang; Dong, Keqin; Guo, Peiyuan; Shan, Meng-Jie.

Afiliación

Wang J; The second Department of orthopedics, Hangzhou Fuyang District First People's Hospital, No. 429 Beihuan Road, Fuyang District, Hangzhou 311499, P.R. China.
Gao S; Bethune Second Clinical Medical College of Jilin University, 218Ziqiang Hutong, Nanguan District, Changchun City, Jilin Province 130041, China.
Dong K; School of Basic Medical Sciences, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Hebei 050017, P.R. China.
Guo P; School of Basic Medical Sciences, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Hebei 050017, P.R. China.
Shan MJ; Graduate School, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 9 Dongdansantiao, Dongcheng District, Beijing 100730, China.

Medicine (Baltimore) ; 100(39): e27101, 2021 Oct 01.

Article en En | MEDLINE | ID: mdl-34596111

Asunto(s)

Biomarcadores de Tumor/genética; Miosinas Cardíacas/genética; Regulación Neoplásica de la Expresión Génica; Cadenas Ligeras de Miosina/genética; Rabdomiosarcoma/genética; Rabdomiosarcoma/mortalidad; Humanos; Pronóstico; Tasa de Supervivencia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Cadenas Ligeras de Miosina / Miosinas Cardíacas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2021 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google